Statins are associated with a lower risk of dementia in patients with type 2 diabetes, a new study found. Researchers tracked more than 132,000 people between 2006 and 2021, finding that early intervention with widely prescribed cholesterol-lingering drugs like Atorvastatin and Simvastatin can reduce the likelihood of developing the disease by up to 15%. Statin … Read more
Atorvastatin reduced major cardiovascular events by 30 percent in older adults without known cardiovascular disease, diabetes, or dementia, according to findings presented at the ESC Congress 2026 and published in the New England Journal of Medicine. Led by researchers at Monash University, the STAREE trial evaluated 9,971 participants aged 70 and older over a median … Read more
Recent findings from a large UK Biobank analysis published in the journal Alzheimer’s & Dementia indicate that hormone replacement therapy use is associated with a modest 10% reduction in all-cause dementia risk among postmenopausal women, though the effect varies significantly depending on menopause type, estrogen exposure duration, and the timing of treatment initiation. UK Biobank … Read more
Researchers at the Mass General Brigham Neuroscience Institute have discovered that a specific pattern of brain shrinkage visible on MRI scans can help predict how quickly individuals with early-onset Alzheimer’s disease progress from mild cognitive impairment to dementia, according to findings published in the journal Neurology. MRI Brain Atrophy Predicts Early-Onset Alzheimer’s Progression Early-onset Alzheimer’s … Read more
Accelerated biological age (ABA) in midlife serves as a significant predictor for cardiovascular disease, dementia, and mortality, according to a longitudinal study published in Scientific Reports. Researchers analyzing nearly three decades of data from the Framingham Offspring Study found that individuals with a higher biological age than their chronological age faced elevated risks of these … Read more
University of Houston College of Pharmacy researchers secured more than $1 million in new funding to tackle three distinct healthcare challenges, including sepsis, Alzheimer’s disease, and sickle cell-related depression, according to institutional announcements. The grants back projects aimed at developing new drug delivery systems, artificial intelligence tools, and specialized diagnostic screeners to improve patient outcomes. … Read more
A biological age score derived from four common blood markers—chronological age, creatinine, blood glucose, and C-reactive protein (CRP)—successfully predicted future cognitive impairment in middle-aged and older adults, according to a study published in Scientific Reports. Researchers found that this “light BioAge” index provides a more nuanced look at cognitive risk than age alone, offering a … Read more
Former San Francisco 49ers running back Roger Craig announced he has vascular dementia during his Pro Football Hall of Fame induction speech in Canton, Ohio, stating that his doctors believe the condition may be related to his playing-career concussions. According to the Associated Press, Craig delivered the news nearly eight minutes into a nine-minute pre-recorded … Read more
According to a study published in Neurology Open Access, avoiding smoking, managing high blood pressure, and preventing Type 2 diabetes can delay the onset of dementia by nearly 13 years. Researchers monitored more than 12,400 dementia-free participants starting at age 55 for an average of 26 years, tracking how cardiovascular risk factors influence cognitive decline … Read more
Researchers at the Sant Pau Research Institute in Barcelona have identified early microscopic white matter abnormalities in Alzheimer’s disease patients using a specialized neuroimaging metric called peak width of skeletonized mean diffusivity, or PSMD. According to a study published in the journal Alzheimer’s & Dementia, this advanced diffusion magnetic resonance imaging tool detects subtle structural … Read more